Supplementary Figure 1 from HGF as a Circulating Biomarker of Onartuzumab Treatment in Patients with Advanced Solid Tumors

Authors :: Priti S. Hegde
Mark R. Lackner
Garret M. Hampton
Amy Peterson
Premal Patel
Robert L. Yauch
Mark Merchant
Kyra J. Cowan
Luciana Burton
Vaishali Parab
Congfen Li
Elicia Penuel
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 22K, Changes in shed Met do not correlate with changes in cHGF over the duration of the first cycle of onartuzumab administration in the Phase 1A study.

Tools